September 30, 2024 TRANSPERS researchers publish JAMA paper on payer coverage considerations for new Alzheimer’s disease tests
May 13, 2024 JAMA publication by TRANSPERS Collaborators Addresses Rapid Emergence of State Biomarker Testing Insurance Coverage Laws
July 8, 2021 TRANSPERS Awarded 5-Year NIH Grant to Build Evidence Base for Policies on Emerging Genomic Tests
January 8, 2021 Genetics in Medicine Publication by TRANSPERS Analyzes Private Payer Coverage Policies for ApoE Genetic Testing for Late-Onset Alzheimer’s Disease
October 26, 2020 JAMA Publication by UCSF Center for Translational and Policy Research (TRANSPERS) Finds Global Use and Funding of Clinical Genomic Sequencing Expands but More Data on Implementation Are Needed
August 14, 2020 TRANSPERS awarded NIH grant to tackle challenges of using precision medicine to identify risk for Alzheimer’s and related dementias
July 7, 2020 TRANSPERS Study Finds Increase in Coverage for Liquid Biopsy (ctDNA sequencing) for both Private Payers and Medicare - but Broader Pan-Cancer Coverage under Medicare
May 8, 2020 Set of Papers in Value In Health Address Methods for Moving Evaluation of Precision Medicine into Practice and Policy
September 12, 2019 TRANSPERS & UCSF P3EGS publish study in GIM, finding 71% of private payers now cover pediatric Exome Sequencing (ES) but no payers covered prenatal ES
May 30, 2019 TRANSPERS JAMA Publication Is First to Examine Policy Implications of Emergence of New Model for Genetic Testing
September 14, 2018 Value In Health September issue addresses challenges and solutions for assessment of the value of clinical genomic testing
August 15, 2018 TRANSPERS Researchers Find Increase in Private Payer Coverage of Whole Exome Sequencing in collaboration with the NHGRI-funded UCSF Program in Prenatal and Pediatric Genome Sequencing
July 13, 2018 Moving into the Next Decade of NIH Funding: UCSF TRANSPERS Receives $2.3M in NCI Funding to Study Economics and Decision-Making for Precision Medicine
June 12, 2018 UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) Addresses Rapid Evolution of Genomic Sequencing in two Washington Post Articles
April 17, 2018 TRANSPERS publication in JAMA lays out health policy agenda on new CMS coverage policy for sequencing tests in cancer patients
April 13, 2017 New TRANSPERS study teams up with leading experts to identify evidence gaps in genomic medicine that comparative effectiveness research can address
February 16, 2017 New TRANSPERS Study Identifies Opportunities to Resolving Reimbursement Challenges for Genetic Panel Tests for Cancer Risk Assessment
February 10, 2017 Value In Health features TRANSPERS papers and commentary on assessing the value of precision medicine and other Big Data technologies